Size: 60 Capsules
Because MegaSporeBiotic is made from soil based spore-forming organisms, they reach the digestive tract in full potency. Studies have shown that leading probiotic formulas containing Lactobacillus and Bifidobacteria are drastically reduced or completely killed by heat and stomach acids.
Contains five well researched strains of soil-based organisms that create favorable conditions to promote the growth of your resident “good” bacteria, like Lactobacillus and Bifidobacteria species.
Product Questions? Please see our MegaSporeBiotic FAQ page for answers to common questions about this product.
Size: 50 Capsules
RestorFlora is the first therapeutic probiotic product that combined three well studied and widely used probiotic strains: Saccharomyces boulardii, Bacillus subtilis HU58 and Bacillus clausii.
Several clinical studies show that the friendly yeast S. boulardii (also called Sac. B) is helpful for support with gut disorders1, especially gut bacterial challenges, antibiotic-associated diarrhea and C. difficile associated diarrhea2 *. The unique properties of S. boulardii make it a beneficial addition to a probiotic regimen when extra support is needed for difficult gastrointestinal challenges.
Dual action support is achieved by the addition of B. subtilis HU58 and B. clausii, which help support immune system function and the reduction of GI inflammation.*
Convenience, Quality and Value
MegaSporeBiotic and RestorFlora require no refrigeration, making them easy to store, ship, and travel with. The products are made in a GMP facility to ensure maximum quality, potency and batch-to-batch consistency. We offer these physician’s-strength probiotics at the lowest pricing allowed by the manufacturer.
Product Questions? Please see our RestorFlora FAQ page for answers to common questions about this product.
- Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts. Vandenplas Y, July 1999, Clin. Microbiol. Infect. 5 (7): 389–395
- Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea. Surawicz CM, July 2018, J Clin Gastroenterol. 42 (Suppl 2): S64–70
* FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.